<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02373800</url>
  </required_header>
  <id_info>
    <org_study_id>LOCAL/2013/VL-02</org_study_id>
    <secondary_id>2014-A00828-39</secondary_id>
    <nct_id>NCT02373800</nct_id>
  </id_info>
  <brief_title>Elastography for Evaluating Cervical Maturity in Preparation for Labor Induction at 37 to 42 Weeks of Gestation</brief_title>
  <acronym>ElastoDéclench</acronym>
  <official_title>Elastography for Evaluating Cervical Maturity in Preparation for Labor Induction at 37 to 42 Weeks of Gestation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to determine if a cervical hardness score (determined
      by cervical ultrasound with elastography) can predict delivery mode (vaginal versus cesarian
      for slow dilatation (more than 2-3h without fetal suffering) regardless of the induction mode
      (ocytocin alone or with an intravaginal device releasing PGE2).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The secondary objectives of this study are:

      A. To determine composite criteria (combining elastographic, parity and Bishop score
      information) that predict delivery mode.

      B. To determine the prognostic value of elastography as concerns delivery within 24 hours
      among patients induced via oxytocin with an intravaginal device releasing PGE2 (Bishop score
      &lt; 6).

      C. To determine the prognostic value of elastography as concerns delivery mode (vaginal
      versus cesarian for slow dilatation (more than 2-3h without fetal suffering))among patients
      induced via oxytocin alone.

      D. To evaluate the intra- and inter-operator reproducibility of the cervical hardness score
      determined via elastography.

      E. To evaluate the economic impact of using the cervical hardness score from the point of
      view of the French social system (French health insurance) and the hospital.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 4, 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cervical hardness score</measure>
    <time_frame>Day 0 (baseline)</time_frame>
    <description>A score varying from 0 to 10 determined during cervical ultrasound with elastography.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mode of delivery: vaginal delivery versus cesarean</measure>
    <time_frame>Day 2</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bishop score</measure>
    <time_frame>Day 0 (baseline)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parity</measure>
    <time_frame>Day 0 (baseline)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time lapsed between labor induction and delivery</measure>
    <time_frame>Day 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Induction mode</measure>
    <time_frame>Day 0 (baseline)</time_frame>
    <description>oxytocin alone or with an intravaginal device releasing PGE2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cervical hardness score for reproductibility 1</measure>
    <time_frame>Day 0 (baseline)</time_frame>
    <description>Second reading (by the same, original operator) of ultrasound+elastography recording</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cervical hardness score for reproductibility 2</measure>
    <time_frame>Day 0 (baseline)</time_frame>
    <description>Third reading (by a second operator) of ultrasound+elastography recording</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost of hospital stay</measure>
    <time_frame>Expected average of 4-5 days</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Age in years</measure>
    <time_frame>Day 0 (baseline)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Body mass index</measure>
    <time_frame>Day 0 (baseline)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Number of previous vaginal deliveries</measure>
    <time_frame>Day 0 (baseline)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Duration of labor</measure>
    <time_frame>Day 2</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Birthweight of the newborn</measure>
    <time_frame>Day 2</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Maternal complications</measure>
    <time_frame>Day 2</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Complications for the newborn</measure>
    <time_frame>Day 2</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Indication for cesarian: fetal cause, cervical cause, non descent</measure>
    <time_frame>Day 2</time_frame>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Labor, Induced</condition>
  <arm_group>
    <arm_group_label>The study population</arm_group_label>
    <description>The study population is composed of pregnant women with a medical indication for the induction of pre-term (37-42 weeks of gestation) labor and who are consulting in the participating center.
Intervention: Cervical ultrasound with elastography</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cervical ultrasound with elastography</intervention_name>
    <description>Following routine vaginal exam with determination of Bishop's score, cervical ultrasound with elastography will be used to determine a cervical hardness score varying from 1 to 10. Patients are then hospitalized and labor induced 12 to 48 hours after the elastography.</description>
    <arm_group_label>The study population</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population is composed of pregnant women with a medical indication for the
        induction of pre-term (37-42 weeks of gestation) labor and who are consulting in the
        participating center.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient must have given her informed and signed consent

          -  The patient must be insured or beneficiary of a health insurance plan

          -  Pregnant woman with a medical indication for pre-term labor induction: 37 to 42 weeks
             of gestation.

        Exclusion Criteria:

          -  The patient is in an exclusion period determined by a previous study

          -  The patient is under judicial protection, under tutorship or curatorship

          -  The patient refuses to sign the consent

          -  It is impossible to correctly inform the patient

          -  History of cervical surgery

          -  Malformation of the cervix
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincent Letouzey, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vincent Letouzey, MD</last_name>
    <phone>+33.(0)4.66.68.32.16</phone>
    <email>vincent.letouzey@chu-nimes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carey Suehs, PhD</last_name>
    <phone>+33.(0)4.66.68.67.88</phone>
    <email>carey.suehs@chu-nimes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHRU de Nîmes - Hôpital Universitaire Carémeau</name>
      <address>
        <city>Nîmes Cedex 09</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Vincent Letouzey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eve Mousty, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Renaud de Tayrac, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre Marès, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arnaud Corille, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frédéric Grosjean, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2015</study_first_submitted>
  <study_first_submitted_qc>February 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2015</study_first_posted>
  <last_update_submitted>October 31, 2017</last_update_submitted>
  <last_update_submitted_qc>October 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Induced</keyword>
  <keyword>pre-term labor</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

